Keeping Track: Pfizer’s Talzenna Ensures Record Year For Novel US Approvals; Novartis Submits SMA Gene Therapy

 
• By Bridget Silverman, Michael Cipriano, and Sue Sutter

The latest drug development news and highlights from our FDA Performance Tracker.

Keeping Track Feature image

More from Product Reviews

More from Pink Sheet